作者：
Borgeg?rd,T. [1]
;
Gustavsson,S. [2]
;
Nilsson,C. [3]
;
Parpal,S. [4]
;
Klintenberg,R. [5]
;
Berg,A.-L. [6]
;
Rosqvist,S. ;
Serneels,L. ;
Svensson,S. ;
Olsson,F. ;
Jin,S. ;
Yan,H. ;
Wanngren,J. ;
Jureus,A. ;
Ridderstad-Wollberg,A. ;
Wollberg,P. ;
Stockling,K. ;
Karlstr?m,H. ;
Malmberg,?. ;
Lund,J. ;
Arvidsson,P.I. ;
DeStrooper,B. ;
Lendahl,U. ;
Lundkvist,J.
作者单位：
Center for Human Genetics and Leuven Institute for Neurodegenerative Disorders (LIND), University
[1]
Department of Neurobiology, Caring Sciences and Society, KI-Alzheimer Disease Research Center
[2]
AstraZeneca, CNS and Pain Innovative Medicines, SE-15185 S?dert?lje, Sweden, Department of
[3]
AstraZeneca, CNS and Pain Innovative Medicines, SE-15185 S?dert?lje, Sweden
[4]
Department of Cell and Molecular Biology, Karolinska Institute, SE-17177 Stockholm, Sweden
[5]
AstraZeneca, CNS and Pain Innovative Medicines, SE-15185 S?dert?lje, Sweden, Organic Pharmaceutical
[6]
发布时间
2013-11-20
换一批
